FDA Issues Marketing Denial Order for 22 SMOK E-cigarette Products

Regulations by 2FIRSTS.ai
Jan.17.2024
FDA Issues Marketing Denial Order for 22 SMOK E-cigarette Products
The US FDA has issued a Marketing Denial Order for 22 SMOK brand e-cigarette products from Shenzhen IVPS Technology Co., Ltd.

On January 16th, the U.S. Food and Drug Administration (FDA) issued Marketing Denial Orders (MDOs) against 22 SMOK brand e-cigarette products from Shenzhen IVPS Technology Co., Ltd, based in Shenzhen, China. The products that were denied marketing approval included devices, e-liquid cartridges, atomizers, and pods, which are marketed as part of the e-cigarette system but do not contain e-cigarette e-liquid.

 

The FDA explained that the company is prohibited from promoting or distributing these products in the US market, or else they will face enforcement actions by the FDA. After reviewing the company's PMTAs, the FDA concluded that these applications lack sufficient evidence to demonstrate that allowing these products to enter the market would be appropriate for public health, as required by the 2009 Family Smoking Prevention and Tobacco Control Act. Specifically, the applicants failed to provide sufficient data to describe ingredient release, product stability, and product misuse risks.

 

The rejected SMOK e-cigarette products did not come with e-cigarette liquid. Consumers are required to separately purchase and add their own e-cigarette liquid to the device. Therefore, these SMOK products have the potential to be used with any e-cigarette liquid available on the market, including both tobacco and non-tobacco flavors. According to the 2023 National Youth Tobacco Survey (NYTS), SMOK is reported as the sixth most popular brand among teenage e-cigarette users, with 11.3% of high school students reporting use of SMOK products in the past 30 days.

 

Dr. Brian King, Director of the Center for Tobacco Products (CTP) at the FDA, stated:

 

Science serves as the foundation of the FDA tobacco product review process, and CTP remains committed to evaluating tobacco products based on public health standards, taking into consideration the risks and benefits posed by such products to the entire population. It is the responsibility of the applicant to provide sufficient scientific evidence to demonstrate that the introduction of a new tobacco product into the market is appropriate for safeguarding public health. In this particular case, the applicant failed to provide this evidence.

 

After undergoing rigorous scientific scrutiny by the FDA, tobacco products that receive a Marketing Denial Order (MDO) are prohibited from being introduced or delivered into interstate commerce. If these products are currently being sold on the market, they must be withdrawn. The manufacturers, distributors, and retailers selling or distributing these products in interstate markets will be in violation of the law and may face enforcement actions. The FDA provides the latest information on MDOs, including updates or changes, such as revocations or relevant court rulings, on its Tobacco Product Marketing Orders webpage. However, companies can submit new applications for products that are subject to these MDOs.

 

The FDA also stated that this action is part of its ongoing efforts to ensure that all new tobacco products cannot be legally marketed until they have undergone science-based evaluation and obtained FDA marketing authorization.

 

Since 2020, the FDA has received over 26 million applications for products and has made decisions on 99% of these applications. So far, the FDA has authorized 23 e-cigarette products and devices with tobacco flavors. To enable retailers, consumers, and others to know which products can be legally marketed, the FDA has provided a list of e-cigarette products and devices that have obtained marketing authorization orders (MGOs). Additionally, the FDA has rejected the marketing applications for millions of products that failed to meet the necessary public health standards required by law.

 

The following is a list of products that have been issued MDOs:

 

  • SMOK OSUB ONE Device
  • SMOK OSUB ONE RPM Cartridge
  • SMOK RPM DC 0.8 Ω MTL Atomizer
  • SMOK OSUB ONE RPM Cartridge 3 Pack
  • SMOK RPM DC 0.8 Ω MTL Atomizer 5 Pack
  • SMOK Nfix Device
  • Nfix DC 0.8 Ω MTL Pod
  • SMOK POZZ Device
  • SMOK POZZ DC 0.8 Ω Pod
  • SMOK RPM 40 Device
  • SMOK RPM Empty Standard Cartridge
  • SMOK RPM Empty Nord Cartridge
  • SMOK RPM Mesh 0.4 Ω Atomizer
  • SMOK Nord DC 0.8 Ω MTL Atomizer
  • SMOK SCAR-P3 Device
  • SMOK SCAR-P3 Empty RPM 2 Cartridge
  • SMOK SCAR-P3 Empty RPM Cartridge
  • SMOK PRM 2 Mesh 0.16 Ω Atomizer
  • SMOK RPM Mesh 0.4 Ω Atomizer
  • SMOK Nord 2 Device
  • SMOK Nord 2 RPM Cartridge
  • SMOK Nord 2 Nord Cartridge

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

2Firsts Analysis: 69.8% of North American Cannabis Vapes Lack Clear Ingredient Labeling, Raising Compliance and Safety Concerns
2Firsts Analysis: 69.8% of North American Cannabis Vapes Lack Clear Ingredient Labeling, Raising Compliance and Safety Concerns
In August 2025, the Journal of Studies on Alcohol and Drugs published a study analyzing the packaging of Delta-8 THC products in North America. 2Firsts focused on the cannabis vape segment, which accounts for 37.9% of the sample, often with high concentrations—yet 69.8% lacked clear potency information, and only 11.7% carried health warnings on the main display panel.
Aug.15 by 2FIRSTS.ai
Egypt Tops Global Hookah Exports in 2024, with Middle East and North Africa as Key Markets
Egypt Tops Global Hookah Exports in 2024, with Middle East and North Africa as Key Markets
In 2024, Egypt remained the world’s largest exporter of hookah tobacco (maassel), accounting for 32% of global exports with a total value of $127.4 million and a volume of 27,000 tons. Its growth is driven by a strong local production base, competitive pricing, and diverse flavors. Key markets—Iraq, Libya, Syria, Saudi Arabia, and Kuwait—collectively make up 70% of its exports.
Jul.22 by 2FIRSTS.ai
Scotland E-Cigarette Market Report (3): Nicotine Pouch Sales Up 51% Year-on-Year, Top 5 Brands Capture 97% Market Share
Scotland E-Cigarette Market Report (3): Nicotine Pouch Sales Up 51% Year-on-Year, Top 5 Brands Capture 97% Market Share
Talysis data shows strong growth in oral nicotine sales in Scottish convenience stores pre- and post-ban. By May 2025, market share hit 1.1% (58% growth), rising to 1.3% (51% growth) post-ban. The top five brands capture 97% of sales, with Velo and Nordic leading. UK nicotine pouch sales reached £158 million ($200 million), up 71%, with convenience stores seeing the fastest growth and brands like XQS launching new flavors.
Aug.06 by 2FIRSTS.ai
BAT CFO Transition: Soraya Benchikh Steps Down, Digital & Information Director Javed Iqbal to Serve as Interim Successor
BAT CFO Transition: Soraya Benchikh Steps Down, Digital & Information Director Javed Iqbal to Serve as Interim Successor
British American Tobacco (BAT) announced that its current Chief Financial Officer (CFO) and Board member, Soraya Benchikh, will step down from her role effective August 26, 2025, and will continue to support the transition until December 31, 2025. The company has initiated the selection process for a permanent successor. In the meantime, current Digital & Information Director Javed Iqbal will serve as Interim CFO.
Aug.27 by 2FIRSTS.ai
 KT&G Q2 earnings: net profit falls 54% to $103 million, NGP revenue down 0.8% to $141 million
KT&G Q2 earnings: net profit falls 54% to $103 million, NGP revenue down 0.8% to $141 million
KT&G has released its financial report for the second quarter and first half of 2025. The company's first-half revenue surpassed 3 trillion won (approximately US$2.16 billion) for the first time, with second-quarter revenue increasing by 8.7% year-over-year to US$1.114 billion. Net profit decreased by 54.1% year-over-year to US$103 million.
Aug.08 by 2FIRSTS.ai
Singapore Authorises 5,000+ Officers to Enforce Tougher Vaping Laws; 232 Fined in First Week
Singapore Authorises 5,000+ Officers to Enforce Tougher Vaping Laws; 232 Fined in First Week
Singapore has nearly doubled its frontline enforcement force against vaping, authorising more than 5,000 officers across multiple agencies. In the first week since enhanced laws took effect on Sep 1, authorities fined 232 people; at least 14 were confirmed with etomidate-laced “Kpods,” and 32 were suspected of using them.
Sep.09